To assess the tolerabilit y of an acid vehicle to be used in toxicology studies, a low pH aqueous solution containing 16.4 mg=ml of citric acid, 4.2 mg=ml of disodium phosphate, 25 mg=ml of mannitol, adjusted with phosphoric acid=NaOH 1 M to pH 3 was daily adm inistered intravenously to rats and dogs for 14 consecutive days. T he dosing regimen consisted of a slow intravenous bolus injection given over 30 s (0.75 and 0.625 ml=kg, for rats and dogs, respectively) followed by intravenous infusion for one hour (3.75 and 2.75 ml=kg=h, for rats and dogs, respectively). In rats, the dose was administered via the lateral tail vein. In dogs, the intravenous bolus dose was administered via the vena cephalica, vena saphena or vena jugularis, whilst the infusion dose was given into the vena cephalica or vena saphena. In rats, administrat ion of the vehicle was associated with clinical signs (occasional mild vocalizati on and agitati on) which were considered to be due to local irritat ion during the dosing procedure. Nevertheless, only mild histopathological changes at the injection site were found, while no relevant clinical chemistry changes were found in this species. However, the vehicle caused signi®cant vascular damage with thrombus formation in the dog. It is therefore concluded that this vehicle is suitable for 2-week rat toxicity studies, if carefully applied. T he vehicle with its present regimen should not be used in dogs, in view of the prohibitive ®ndings.
Summary
To assess the tolerabilit y of an acid vehicle to be used in toxicology studies, a low pH aqueous solution containing 16.4 mg=ml of citric acid, 4.2 mg=ml of disodium phosphate, 25 mg=ml of mannitol, adjusted with phosphoric acid=NaOH 1 M to pH 3 was daily adm inistered intravenously to rats and dogs for 14 consecutive days. T he dosing regimen consisted of a slow intravenous bolus injection given over 30 s (0.75 and 0.625 ml=kg, for rats and dogs, respectively) followed by intravenous infusion for one hour (3.75 and 2.75 ml=kg=h, for rats and dogs, respectively). In rats, the dose was administered via the lateral tail vein. In dogs, the intravenous bolus dose was administered via the vena cephalica, vena saphena or vena jugularis, whilst the infusion dose was given into the vena cephalica or vena saphena. In rats, administrat ion of the vehicle was associated with clinical signs (occasional mild vocalizati on and agitati on) which were considered to be due to local irritat ion during the dosing procedure. Nevertheless, only mild histopathological changes at the injection site were found, while no relevant clinical chemistry changes were found in this species. However, the vehicle caused signi®cant vascular damage with thrombus formation in the dog. It is therefore concluded that this vehicle is suitable for 2-week rat toxicity studies, if carefully applied. T he vehicle with its present regimen should not be used in dogs, in view of the prohibitive ®ndings. Keywords Intravenous; low pH, tolerability; rat; dog T he intravenous route of administrat ion is frequently used in man and animals for many classes of drugs. T his route generally provides a rapid induction of effects. Exposure to a drug can be controlled by simply varying the rate of infusion. Moreover, poor oral bioavai labili ty can easily be bypassed by the intravenous route of administrati on.
Preferably, the compound should be dissolved in an easy to handle and welltolerated aqueous solution like saline (Salauze & Cave 1995) . In the pharmaceutical industry, solubility and membrane permeability of new compounds has dropped in recent years. T his trend may be related to new research approaches like the exploration of novel targets and the use of combinatorial chemistry. Within the series of newly synthesized compounds, some are only soluble at relatively low pH levels. Other compounds are only stable at low pH levels. T herefore, there is a growing demand for aqueous formulations of low pH.
Looking at intravenous drugs on the market, it appears that the pH of a formulation should be in the range of 4±8, although after administrat ion of small volumes a wider range may be used (Sweetana & Akers 1996 ) . It is well known that the risk of haemolysis, precipitation, phlebitis and pain is markedly higher at low pH levels (Avis e t a l. 1986, Yalk owsky e t a l. 1998). Relatively large volumes and doses are required in single and multiple dose toxicity studies to reveal potential toxic hazards of drug substances a nd formulations. Of course, care should be taken to minimize the discomfort of anim als by exposure to irritants, and experiments should be terminated at the point where severe adverse effects are seen. However, it is not always possible to evaluate beforehand the degree of discomfort that can be expected, considering the fact that surprisingly little literat ure is available on the tolerabi lity of form ulations with (m oderately) low pH, especially as the formulation has to be used with a relative large dose volume, e.g. above 0.5 ml=kg.
Two-week intravenous regulatory toxicology studies of a promising candidate drug in a low pH formulation were conducted to support studies in man. We present here the tolerability=toxicology data obtained in control groups of rats and dogs treat ed with the buffered relative low pH 3 formulation, in order to contribute to the knowledge in this ®eld, and to minimize the need for tolerability studies in this ®eld. T he pH of the form ulation is slightly lower than the pH of intravenous drugs on the market.
Materials and methods
All studies were performed in compliance with Good Laboratory Practices (GLP). T he in-life phase of the studies were performed at lnveresk Research (Tranent, Scotland) and Notox BV ('s-Hertogenbosch, T he Netherlands), for rats and dogs, respectively. Study procedures were according to OECD toxicity testing guidelines. T hese studies complied with the Dutch Act on Animal Experimentati on and the Royal Decree on Animal Experimentation of the UK. T he study was approved by the Animal Experimentation Committee.
Te st fo rm ula tio n (ve h ic le )
T he test formulation is made up of 16.4 mg=ml of citric acid, 4.2 mg=ml of disodium phosphate, 25 mg=ml of mannitol with phosphoric acid=NaOH 1 M to pH 3. T he osmolarity was approximately 434 mOsm=kg. T his formulation has signi®cant buffer capacity to prevent uninhibited instantaneous rise of the pH upon mixing with blood. In vitro , it was checked that there was no chance of precipitation after injection in humans, i.e. human blood was mixed with the vehicle in the appropriate volume-range.
Anim a ls
Sprague Dawley rats (SPF-bred) were obtai ned from Charles River Limited, Margate, Kent, UK. On arrival, the rats were in the weight range 231±257 g for males and 169±188 g for females. Beagle dogs (Hsd=Cpb:DoBe, pure bred) of approximately 5±6 months (body weight range approximately 8±9 kg) were supplied by Harlan Winkelmann (Borchen, Germany).
Ho using, ac c o m o d a tio n a nd d ie t
Ra ts T he animals were housed individually in rooms with a controlled temperature of 20 3 C and a relative humidity of 29±69% , with a room air¯ow giving a minimum of 15 air changes per hour. A 12 h light=dark cycle was used. T he rats were housed in customized polypropylene cages with stainless steel grid tops. Rat and mouse (m odi®ed) No. 1 Diet SQC Expanded, supplied by Special Diets Services, 1 Step®eld, Witham, Essex was available a d li b itum . T he anim als had access to domestic mains quality drinking water a d lib it um .
Do gs Air-conditioned rooms with approximately 15 air changes per hour, a temperature of 18±25 C and a relative humidity of 40±80% . Lighting was 12 h art i®cial¯uorescent light (nightlight during the night period). T he dogs were housed in stainless steel cages with Tenderfoot¯oors. T he standard dog maintenance pelleted food (Altromin diet 4029 extrudat ) supplied by Altromin GmbH (Lage, Germany) was used as diet. Tap water was provided a d lib itu m .
Ac clim a tiza tio n, d o sing a nd d osing sc h e m e
Since a convenient set of historical bac kground data on the usual arising ®ndings (including clinical signs, histopathology, haematology and clinical chemistry) is available for this routinely performed type of study at the labs, and parall el studies including controls with saline were perform ed by the same technicians in the same period, no separate saline treated control group was included for ethical reasons. In dogs, pre-test blood samples were taken for haematology, clinical chemistry and urinalysis (see below). T he rats were allowed to acclim at ize for a minimum period of one week prior to the commencement of dosing. During this week, the rats were gradually conditioned to the restraining procedures used for dosing. T he dogs had an accommodat ion period (with some conditioning to study procedures) of one month. T he dosing regim en is outlined in Table 1 . T he vehicle solution was administered via an initial intravenous (bolus) injection followed by one hour intravenous infusion, daily, for 14 consecutive days. To reach the maximal tolerated dose of the drug-candidate in drug-treated groups (results not shown), dose volumes in rats were 30% larger than in the dog in proportion to body weight (see Table 1 ). T he rats were restrained in a clear, tapered, polycarbonate tube with an adjustable bac kstop. Dose administration was undertaken using a Vygon mini-vein cannula (27 gauge) connected to a 2-way tap introduced into the lat eral tai l vein. T he Vygon mini-vein sets were used for the daily dose administration and were disposed after each usage. Prior to the commencement of dosing, the infusion line was primed with about 0.75 ml of 0.9% NaCl followed by a dose administration of the vehicle, and on completion of dosing, a slow (¯ush) infusion of 0.9% NaCl was given over approximately 15 min. T he infusion adm inistration was controlled using a Medfusion infusion pump (Medex, Haslingden, Rossendale, UK). In the dogs, intravenous bolus dose into the vena cephalica, vena saphena or vena jugularis was given using a¯exible cat heter (Vasocan Braunule), connected to a disposable syringe, while the infusion dose was given into the vena cephalica or vena saphena using an infusion pump (Braun, Germany) (see Results section). Animals were restrained in a sling-type restraining device during infusion. T he catheter was rinsed with a few millilitres of sterile physiological saline before being removed. During the experiment, it was decided to alternate (see Results section) between the (left =right) fore-and hindleg veins (alternately into the vena cephalica, vena saphena or vena jugularis).
Inve stiga tio ns
T he anim als were observed at least twice each day for signs of ill health, mortality or treatm ent-relat ed clinical signs or changes in The bolus dose given over 30 s is followed by an infusion for one hour behaviour. Body weights and food consumption were recorded weekly commencing one week pretrial. Physiological investigations of respiration and electrocardiography were undertaken on Days 1 and 14 of the dosing period, whilst rectal temperature measurements were taken daily throughout the dosing period. Routine laboratory investigations including haemat ology, coagulation, clinical chemistry and urinalysis were undertaken pre-test (for dogs) and at the end of the dosing period (for rats and dogs). For haematology, the following parameters were measured on whole blood tak en into tubes contai ning EDTA as an anticoagulant: haemoglobin, red blood cell count, haematocrit, mean cell volume, mean cell haemoglobin, mean cell haemoglobin concentration, reticulocyte count, total white blood cell count, differential white blood cell count, neutrophils, lym phocytes, monocytes, eosinophils, basophils, large unclassi®ed cells (rat ), platelet count, red cell distribution width, platelet distribut ion width, and mean platelet volume. For coagulati on the following parameters were measured in blood with citrate as an anticoagulant: prothrombin time, act ivated partial thromboplastin time.
For clinical chemistry the following parameters were assayed on plasm a separated from whole blood taken into tubes containing lithium heparin as an anticoagulant: urea, glucose, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gam ma glutamyl transferase (dog), lactate dehydrogenase, sodium , potassium, chloride, total protein, album in, globulin, album ine:globuline ratio, cholesterol, triglycerides, creatinine, total bilirubin, calcium, phosphate, haemoglobin index, and creatine kinase (dog). For urinalysis the following parameters were assayed: appearance, colour, volume, speci®c gravity, osmolality, pH, protein, glucose, ketones, urobilinogen, bilirubin, blood pigments, and microscopy of the spun deposit. On completion of the 14-day dosing period the rat s and dogs were sacri®ced and necropsied. T he rats were killed by exposure to carbon dioxide followed by exsanguination. Dogs were exsanguinat ed via the carotid arteries under deep thiopentone sodium (Nesdonal 1 ) anaesthesia. Organ weights were determined (viz adrenals, brain, epididymis, heart, kidneys, liver, lung, ovaries, pituitary, prostate, spleen, testis, thymus, thyroids, and uterus) and histopathological exam ination was carried out on adrenals, aorta, brain, epididym is, eyes, femur, stomach, duodenum, jejunum, ileum, caecum, colon, rectum , heart, infusion site, kidneys, liver, gall bladder (dog), lungs, mesenteric lymph node, oesophagus, optic nerve, ovaries, pancreas, parathyroids, pituitary, prostate, sciat ic nerve, seminal vesicles (rat ), skeletal muscles, skin, mammary gland, spinal cord, spleen, sternum, salivary glands, testis, thymus, thyroids, tongue, trachea, urinary bladder, uterus, and vagina. T issues were ®xed in 10% neutral buffered formalin (testis ®xed in Bouin and eyes ®xed in Davidson's¯uid) and sections were cut (4±6 mm thick) and stained with haematoxylin and eosin. Special attent ion was given to the injection sites, which were additionally stained using the Marti us-Scarlet Blue method (MSB) for the better visualization of thrombi.
Results
T he results of the study are summarized in Tables 2 and 3 .
Ra ts
In the rat, during dosing, occasional periods of vocalizati on in some anim als, intermittent periods of agitation on several days in all animals and occasional struggling in the restraining tube in a few animals were noted throughout the 2-week dosing period. T hese signs were considered to be attributable to the administration of the vehicle solution. Unkempt, wet and stained coats were also observed with the majority of the animals on the completion of dosing. T hese signs are commonly noted in rat s undergoing restraining in a tube. Large variations in heart rate and rectal temperature were noted, but no consistent trend in relation to treatment was observed. No relevant changes in haematology, clinical chemistry and urinalysis were observed (data not shown), as compared to the historical bac kground data of the lab (data on ®le, lnveresk Research, Scotland), and the reference data (Wolford e t a l. 1986, Alema Ân e t a l. 1997 ). During necroscopy, no gross pathological ®ndings or effects on organ weights (the latt er being based on historical control values) were observed. Histopathologically, a minimal to mild vasculitis (7 out of 12 rat s), occasionally accompanied by dermatit is, myositis, and hyperkeratosi s in adjacent tissues, was observed at the site of injection. T hese injection site in¯ammations re¯ected the usual range of spontaneously-arising bac kground ®ndings with rat s of this strain in this type of laboratory study and are common ®ndings (Gopinath, e t a l. 1987 , Greaves 2000 . T he mild clinical signs and mild vascular damage noted in the rats were con-sidered to be due to the local irritati on caused by the administration of the solution and=or (mechanical) discomfort due to the dosing technique.
Do gs
On the other hand, in the dog, the dosing procedure caused more mark ed vascular lesions at the sites of injection which did not re¯ect the usual range of spontaneouslyarising back ground ®ndings with dogs of this strain in this type of study. Daily visual inspection showed swelling and=or reddish discoloration of the injection sites in most animals. T herefore, it was decided to alternate between the (left =right) fore-and hindleg veins, in order to minimize the discomfort for the animals and also because dosing A thrombus-derived embolus was found in a lung vessel (one female). In some animals, injection site necrosis and oedema were observed, as well as thickening and=or reddish discoloration of the injection sites becam e dif® cult in one animal. Grossly, the swelling and reddish discoloration was also the principal ®nding. Histologically, the most signi®cant reaction at these sites was thrombus formation. T hrombi were described as fresh, organized and organized= recanalized. With respect to their morphological charac teristics, the stage of the thrombi correlated well with the time spans between treatm ent (result not shown). At the site of treatm ent and in surrounding tissues, haemorrhage, necrosis and oedema had developed, accompanied with mixed in¯ammat ory cell in®ltrates and granulation tissue form ati on corresponding with thickening and=or reddish discoloration of the injection sites, noted grossly. A sporadic thrombusderived embolus was found in a lung vessel of one female anim al.
Areas with slight atrophy of the acini in the exocrine pancreas (one male and one fem ale), related to a decreased number of cytoplasmic zymogen granules were observed. In one male, an increased number of apoptotic pancreatic acinar cells was also observed. T his loss of zymogen granules and an increase in acinar cell apoptosis in the pancreas, without any sign of degeneration or in¯ammation or effects on the pancreas organ weight, probably represents a physiological feature rather than a pathological process (Gopinat h e t a l. 1987 ).
T he changes noted above in dogs were not accompanied by any changes in haematology, clinical chemistry and urinalysis (data not shown), as compared to the pre-test values in dogs and to the historical bac kground data of the lab (data on ®le, Notox BV, T he Netherlands), and the reference data (Wolford e t a l. 1986) . Moreover, no effect on organ weights, as compared to historical control values, was observed.
Discussion
Toxicological evaluation of intravenously administered drugs in animals is often dif®cult because large volumes must be infused to identify a potential hazard of the compound (Mann & Kinter 1993 ) . T his is particularly the case when the physico-chemical properties such as solubility and solubiliza-tion (Sim am ora e t a l. 1996 ), pH and tonicity are not ideal (Avis e t a l. 1986 ). In the studies described in this paper, the effects of repeated administration of a low pH formulation were evaluated. With the dosing scheme used, signi®cant prohibitive ®ndings for further use of this vehicle with the current regim en were found in the dog but not in the rat.
It is dif®cult to make general statements on a typical high dose in an intravenous toxicity test, since these doses will heavily depend on ef®cacy and the adverse effects of the drug. Because of the highest dosages to be tested in our laboratory, it is not uncommon for a total daily volume of about 3 ml=kg to be administered (and the actual evaluated volumes in the current studies were even slightly higher). Of course, the volume should be kept as low as possible to minimize discomfort for the animal, and the experiment should be terminat ed at the point where severe adverse reactions are seen. Rapid infusion of such large volumes of acid formulati ons is prone to give haemolysis, pain, phlebitis and other signs. T herefore, it was decided to rapidly infuse approximately 20% of the volume as a rapid bolus injection over 30 s, followed by a slow intravenous infusion over one hour in order to avoid animal discomfort. Such an approach is defensible if the dose volume given to each animal in 30 s (0.6 ml =kg) still signi®cantly exceeds the anticipated human dose volume. An additional prerequisite for this approach is that the adverse effects should not depend on the maximal plasm a concentration of the drug, and=or a signi®cant safety margin between the human dose (=plasm a level) of the drug and animal dose (=plasma level) should be present.
T he noted discomfort in the rat , as expressed by vocalizat ion and agitation, was relatively mild in this study. However, care should be tak en not to exceed the speed of administration of the vehicle. In a pilot experiment, using higher infusion rates, sig-ni®cantly more discomfort to the anim als (especially if the bolus was given more quickly) was noted. Haemolysis and sig-ni®cant local decrease of the pH of the blood may occur if the threshold limit of the ratio vehicle=blood is exceeded. It is very likely that over®lling of the local vascular system could lead to a local temporary drop in pH, which together with overstretching of the vessel used for injection could cause nerve stim ulation (pain). To study this mechanism, determination of the blood acid base status would be required. Moreover, the calcium binding properties of citric acid may be involved. Although no overall effect on serum calcium was observed, repeated local temporal hypocalcaemic periods, which are known to be linked with extensive cellular damage (Zimmermann & Hulsmann 1966, Nozick e t a l. 1971 ), may cause agitation and local dam age.
In the dogs, much more signi®cant lesions developed, especially thrombus formation, which is an uncommon response in animal safety studies (Gopinath e t a l. 1987). T he initiation of thrombosis in this case was probably triggered by local dam age of the vein wall (primarily the endothelium) by the low pH of the vehicle. Other parameters that should be considered in the context of the thrombus form ation are: (i) technical aspects, such as rate of infusion, total volume, duration of exposure (i.e. dose characteristics), and also the material used; (ii) local haemodynam ic aspects, dependable on diameter of the blood vessel, and blood¯ow in the blood vessel; (iii ) personal skill of the technicians.
In a pilot experiment where only the bolus was given to animals (for 30 s) no thrombi developed(results not shown). It can therefore be concluded that at least the duration of exposure of the vein wall to the vehicle may be an important factor in the induction of endothelial lesions which are severe enough to initiate the cascade leading to thrombosis in the dog. However, from the present dataset it is dif® cult to speculate on which param eters account for the difference between the rat and the dog. Possibly, species-speci®c differences in sensitivity may also be involved.
In conclusion, in our hands, 14-day infusion studies with exposure for one hour to an acid vehicle are feasible in the rat with the presented vehicle and dose regim en. In dogs, further research is needed either to understand the factors involved in the throm bus form ati on with this vehicle or to develop a new tolerable acid vehicle and dose regimen.
